Indian Pharma Monitoring Coronavirus Fallout On Production

Zhejiang Major Supply Base For Intermediates, APIs

07 Feb 2020

With several Chinese manufacturing facilities shut at least till 10 February, Indian pharma companies are keeping a close watch on the evolving coronavirus situation. API inventory can last for a while, but if intermediates supplies don’t resume soon the fallout could be grim.

China and India flags — India Watches Situation In China As Coronavirus Clouds Cast A Shadow On Supplies • Source: Shutterstock

The negatives of globalization can at times outweigh the positives, Indian pharmaceutical manufacturers are discovering yet again.

With India's huge dependence on China for active pharmaceutical ingredients (APIs), the evolving situation there arising from coronavirus infections and...